世界の抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antihemophilic Factor & von Willebrand Factor Complex Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0392 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（5ml、10ml、15ml）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体の市場動向 ・企業の競争状況、市場シェア ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体の種類別市場規模（5ml、10ml、15ml） ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体の用途別市場規模（病院、クリニック） ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体の北米市場規模2016-2027（アメリカ、カナダ） ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体の中南米市場規模2016-2027（メキシコ、ブラジル） ・抗血友病因子（AHF）・フォンウィルブランド因子（VWF）複合体の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（CSL Behring、Grifols、Octapharma） ・結論

Antihemophilic and von Willebrand factor complex is a combination medicine used to treat or prevent bleeding episodes in people with von Willebrand disease. Antihemophilic and von Willebrand factor complex is also used to treat or prevent bleeding episodes in people with hemophilia A.

Market Analysis and Insights: Global Antihemophilic Factor & von Willebrand Factor Complex Market
The global Antihemophilic Factor & von Willebrand Factor Complex market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antihemophilic Factor & von Willebrand Factor Complex market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antihemophilic Factor & von Willebrand Factor Complex market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antihemophilic Factor & von Willebrand Factor Complex market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antihemophilic Factor & von Willebrand Factor Complex market.

Global Antihemophilic Factor & von Willebrand Factor Complex Scope and Market Size
Antihemophilic Factor & von Willebrand Factor Complex market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antihemophilic Factor & von Willebrand Factor Complex market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
5 ml
10 ml
15 ml

Segment by Application
Hospital
Clinic

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
CSL Behring
Grifols
Octapharma

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 5 ml
1.2.3 10 ml
1.2.4 15 ml
1.3 Market by Application
1.3.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Perspective (2016-2027)
2.2 Antihemophilic Factor & von Willebrand Factor Complex Growth Trends by Regions
2.2.1 Antihemophilic Factor & von Willebrand Factor Complex Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antihemophilic Factor & von Willebrand Factor Complex Historic Market Share by Regions (2016-2021)
2.2.3 Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Regions (2022-2027)
2.3 Antihemophilic Factor & von Willebrand Factor Complex Industry Dynamic
2.3.1 Antihemophilic Factor & von Willebrand Factor Complex Market Trends
2.3.2 Antihemophilic Factor & von Willebrand Factor Complex Market Drivers
2.3.3 Antihemophilic Factor & von Willebrand Factor Complex Market Challenges
2.3.4 Antihemophilic Factor & von Willebrand Factor Complex Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Revenue
3.1.1 Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Revenue (2016-2021)
3.1.2 Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Players (2016-2021)
3.2 Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antihemophilic Factor & von Willebrand Factor Complex Revenue
3.4 Global Antihemophilic Factor & von Willebrand Factor Complex Market Concentration Ratio
3.4.1 Global Antihemophilic Factor & von Willebrand Factor Complex Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antihemophilic Factor & von Willebrand Factor Complex Revenue in 2020
3.5 Antihemophilic Factor & von Willebrand Factor Complex Key Players Head office and Area Served
3.6 Key Players Antihemophilic Factor & von Willebrand Factor Complex Product Solution and Service
3.7 Date of Enter into Antihemophilic Factor & von Willebrand Factor Complex Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antihemophilic Factor & von Willebrand Factor Complex Breakdown Data by Type
4.1 Global Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Type (2016-2021)
4.2 Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Type (2022-2027)

5 Antihemophilic Factor & von Willebrand Factor Complex Breakdown Data by Application
5.1 Global Antihemophilic Factor & von Willebrand Factor Complex Historic Market Size by Application (2016-2021)
5.2 Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size (2016-2027)
6.2 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type
6.2.1 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021)
6.2.2 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027)
6.2.3 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2027)
6.3 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application
6.3.1 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021)
6.3.2 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027)
6.3.3 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2027)
6.4 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country
6.4.1 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021)
6.4.2 North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size (2016-2027)
7.2 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type
7.2.1 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021)
7.2.2 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027)
7.2.3 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2027)
7.3 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application
7.3.1 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021)
7.3.2 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027)
7.3.3 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2027)
7.4 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country
7.4.1 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021)
7.4.2 Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size (2016-2027)
8.2 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type
8.2.1 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2027)
8.3 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application
8.3.1 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2027)
8.4 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region
8.4.1 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size (2016-2027)
9.2 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type
9.2.1 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021)
9.2.2 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027)
9.2.3 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2027)
9.3 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application
9.3.1 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021)
9.3.2 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027)
9.3.3 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2027)
9.4 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country
9.4.1 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021)
9.4.2 Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size (2016-2027)
10.2 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type
10.2.1 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2027)
10.3 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application
10.3.1 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2027)
10.4 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country
10.4.1 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 CSL Behring Business Overview
11.1.3 CSL Behring Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.1.4 CSL Behring Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021)
11.1.5 CSL Behring Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.2.4 Grifols Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021)
11.2.5 Grifols Recent Development
11.3 Octapharma
11.3.1 Octapharma Company Details
11.3.2 Octapharma Business Overview
11.3.3 Octapharma Antihemophilic Factor & von Willebrand Factor Complex Introduction
11.3.4 Octapharma Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021)
11.3.5 Octapharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of 5 ml
Table 3. Key Players of 10 ml
Table 4. Key Players of 15 ml
Table 5. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Regions (2016-2021)
Table 9. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Regions (2022-2027)
Table 11. Antihemophilic Factor & von Willebrand Factor Complex Market Trends
Table 12. Antihemophilic Factor & von Willebrand Factor Complex Market Drivers
Table 13. Antihemophilic Factor & von Willebrand Factor Complex Market Challenges
Table 14. Antihemophilic Factor & von Willebrand Factor Complex Market Restraints
Table 15. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Players (2016-2021)
Table 17. Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihemophilic Factor & von Willebrand Factor Complex as of 2020)
Table 18. Ranking of Global Top Antihemophilic Factor & von Willebrand Factor Complex Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antihemophilic Factor & von Willebrand Factor Complex Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antihemophilic Factor & von Willebrand Factor Complex Product Solution and Service
Table 22. Date of Enter into Antihemophilic Factor & von Willebrand Factor Complex Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2016-2021)
Table 26. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Application (2016-2021)
Table 30. Global Antihemophilic Factor & von Willebrand Factor Complex Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size by Country (2022-2027) & (US$ Million)
Table 62. CSL Behring Company Details
Table 63. CSL Behring Business Overview
Table 64. CSL Behring Antihemophilic Factor & von Willebrand Factor Complex Product
Table 65. CSL Behring Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021) & (US$ Million)
Table 66. CSL Behring Recent Development
Table 67. Grifols Company Details
Table 68. Grifols Business Overview
Table 69. Grifols Antihemophilic Factor & von Willebrand Factor Complex Product
Table 70. Grifols Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021) & (US$ Million)
Table 71. Grifols Recent Development
Table 72. Octapharma Company Details
Table 73. Octapharma Business Overview
Table 74. Octapharma Antihemophilic Factor & von Willebrand Factor Complex Product
Table 75. Octapharma Revenue in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021) & (US$ Million)
Table 76. Octapharma Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type: 2020 VS 2027
Figure 2. 5 ml Features
Figure 3. 10 ml Features
Figure 4. 15 ml Features
Figure 5. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Antihemophilic Factor & von Willebrand Factor Complex Report Years Considered
Figure 9. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Antihemophilic Factor & von Willebrand Factor Complex Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Regions: 2020 VS 2027
Figure 12. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Regions (2022-2027)
Figure 13. Global Antihemophilic Factor & von Willebrand Factor Complex Market Share by Players in 2020
Figure 14. Global Top Antihemophilic Factor & von Willebrand Factor Complex Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antihemophilic Factor & von Willebrand Factor Complex as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Antihemophilic Factor & von Willebrand Factor Complex Revenue in 2020
Figure 16. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2016-2021)
Figure 17. Global Antihemophilic Factor & von Willebrand Factor Complex Revenue Market Share by Type (2022-2027)
Figure 18. North America Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type (2016-2027)
Figure 20. North America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application (2016-2027)
Figure 21. North America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2016-2027)
Figure 22. United States Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type (2016-2027)
Figure 26. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application (2016-2027)
Figure 27. Europe Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2016-2027)
Figure 28. Germany Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Antihemophilic Factor & von Willebrand Factor Complex Market Share by Region (2016-2027)
Figure 38. China Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type (2016-2027)
Figure 46. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application (2016-2027)
Figure 47. Latin America Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2016-2027)
Figure 48. Mexico Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Antihemophilic Factor & von Willebrand Factor Complex Market Share by Country (2016-2027)
Figure 54. Turkey Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Antihemophilic Factor & von Willebrand Factor Complex Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. CSL Behring Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021)
Figure 58. Grifols Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021)
Figure 59. Octapharma Revenue Growth Rate in Antihemophilic Factor & von Willebrand Factor Complex Business (2016-2021)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

---